BVXP.L
Price:
$3875
Market Cap:
$202.26M
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2014-04-29
Stock Exchange
LSE
Ticker
BVXP.L
According to Bioventix PLC’s latest financial reports and current stock price. The company's current PE Ratio is 23.63. This represents a change of 95.80% compared to the average of 12.07 of the last 4 quarters.
The mean historical PE Ratio of Bioventix PLC over the last ten years is 23.54. The current 23.63 PE Ratio has changed 9.94% with respect to the historical average. Over the past ten years (40 quarters), BVXP.L's PE Ratio was at its highest in in the January 2011 quarter at 33.93. The PE Ratio was at its lowest in in the June 2016 quarter at 5.91.
Average
23.54
Median
23.69
Minimum
13.91
Maximum
33.02
Discovering the peaks and valleys of Bioventix PLC PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 42.47%
Maximum Annual PE Ratio = 33.02
Minimum Annual Increase = -23.77%
Minimum Annual PE Ratio = 13.91
Year | PE Ratio | Change |
---|---|---|
2023 | 23.97 | 2.35% |
2022 | 23.42 | -23.77% |
2021 | 30.72 | 3.21% |
2020 | 29.77 | -9.84% |
2019 | 33.02 | 23.77% |
2018 | 26.68 | 34.59% |
2017 | 19.82 | 42.47% |
2016 | 13.91 | -19.68% |
2015 | 17.32 | 3.29% |
2014 | 16.77 | -14.67% |
The current PE Ratio of Bioventix PLC (BVXP.L) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
26.04
5-year avg
28.18
10-year avg
23.54
Bioventix PLC’s PE Ratio is less than AB Dynamics plc (32.91), less than Craneware plc (89.85), less than Tristel plc (31.34), greater than Somero Enterprises, Inc. (8.79), greater than Focusrite plc (14.20),
Company | PE Ratio | Market cap |
---|---|---|
32.91 | $448.76M | |
89.85 | $801.83M | |
31.34 | $189.98M | |
8.79 | $164.86M | |
14.20 | $166.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioventix PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioventix PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bioventix PLC's PE Ratio?
How is the PE Ratio calculated for Bioventix PLC (BVXP.L)?
What is the highest PE Ratio for Bioventix PLC (BVXP.L)?
What is the 3-year average PE Ratio for Bioventix PLC (BVXP.L)?
What is the 5-year average PE Ratio for Bioventix PLC (BVXP.L)?
How does the current PE Ratio for Bioventix PLC (BVXP.L) compare to its historical average?